People aging with 4 antiretroviral class resistant HIV are a very challenging population. It is difficult to build up a fully suppressive regimen, and the high prevalence of comorbidities and polypharmacy may cause drug-drug interactions and put adherence at risk. We herein present the case of an 80-year-old man, participating in the PRESTIGIO registry, asking for a reduction in his antiretroviral burden while on polypharmacy for his comorbidities.
Mazzitelli, M., Zazzi, M., Marchetti, G., Spagnuolo, V., Santoro, M.M., Foca, E., et al. (2023). PRESTIGIO RING: “An 80-year-old man living with HIV resistant to all four antiretroviral classes and desiring treatment simplification”. NEW MICROBIOLOGICA, 46(4), 407-411.
PRESTIGIO RING: “An 80-year-old man living with HIV resistant to all four antiretroviral classes and desiring treatment simplification”
Zazzi M.;
2023-01-01
Abstract
People aging with 4 antiretroviral class resistant HIV are a very challenging population. It is difficult to build up a fully suppressive regimen, and the high prevalence of comorbidities and polypharmacy may cause drug-drug interactions and put adherence at risk. We herein present the case of an 80-year-old man, participating in the PRESTIGIO registry, asking for a reduction in his antiretroviral burden while on polypharmacy for his comorbidities.
| File | Dimensione | Formato | |
|---|---|---|---|
|
2023_NM_Mazzitelli_PRESTIGIO_80_yr_old_with_4CR.pdf
accesso aperto
Descrizione: articolo
Tipologia:
PDF editoriale
Licenza:
PUBBLICO - Pubblico con Copyright
Dimensione
537.11 kB
Formato
Adobe PDF
|
537.11 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1278467